2000

Dec 8, 2000
Guidant Announces FDA Approval of the FINELINE II Sterox Family of Pacing Leads

Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiovascular technologies that save and improve lives, today announced that it has received...

Dec 8, 2000
Guidant Launches Clinical Trial to Evaluate its Intravascular Radiotherapy System in Treating Long Coronary Lesions

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced the enrollment of the first...

Jun 12, 2000
Clinical Data Demonstrates Guidant''s ANCURE Bifurcated Endograft System for Abdominal Aortic Aneurysms as a Safe and Effective Minimally Invasive Treatment

Indianapolis, IN and Menlo Park, CA - Two years of clinical data demonstrate that Guidant Corporation''s (NYSE and PCX: GDT) ANCURE(tm) Bifurcated Endograft System is an effective and safe,...

Jun 8, 2000
John C. Jenkins to become Vice President and General Counsel of Guidant Corporation

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that on October 1, 2000 John C. Jenkins will become Vice President and General Counsel of the company, reporting to...

Jun 8, 2000
Guidant Supports the President's Plan to Reimburse Routine Patient Care Costs for Medicare Beneficiaries in Clinical Trial

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, commends President Clinton''s Executive Memorandum taking the first step toward...

Show 5102550100 per page
Top